{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:18:43Z","timestamp":1769573923942,"version":"3.49.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.3892\/or.2014.3481","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T10:11:42Z","timestamp":1410862302000},"page":"2365-2372","source":"Crossref","is-referenced-by-count":40,"title":["miR-379\/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma"],"prefix":"10.3892","volume":"32","author":[{"given":"KAZUO","family":"YAMAMOTO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASAHIRO","family":"SEIKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUSUMU","family":"TAKEUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHIE","family":"SOENO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIHIKO","family":"MIYANAGA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RINTARO","family":"NORO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUJI","family":"MINEGISHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAORU","family":"KUBOTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKIHIKO","family":"GEMMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,9,16]]},"reference":[{"key":"key20180107210345_b1-or-32-06-2365","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14737140.8.2.293","article-title":"Current concepts in malignant pleural mesothelioma","volume":"8","author":"Kaufman","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20180107210345_b2-or-32-06-2365","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1164\/ajrccm.157.1.96-11086","article-title":"Environmental exposure to crocidolite and mesothelioma: exposure-response relationships","volume":"157","author":"Hansen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180107210345_b3-or-32-06-2365","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107210345_b4-or-32-06-2365","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20180107210345_b5-or-32-06-2365","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of PEM in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180107210345_b6-or-32-06-2365","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ejca.2011.11.009","article-title":"Vorinostat\/SAHA-induced apoptosis in malignant mesothelioma is FLIP\/caspase 8-dependent and HR23B-independent","volume":"48","author":"Hurwitz","year":"2012","journal-title":"Eur J Cancer"},{"key":"key20180107210345_b7-or-32-06-2365","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-08-1579","article-title":"Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma","volume":"15","author":"Vandermeers","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107210345_b8-or-32-06-2365","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1158\/1078-0432.CCR-07-0162","article-title":"Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies","volume":"13","author":"Ramalingam","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107210345_b9-or-32-06-2365","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri1936","article-title":"Cancer despite immunosurveillance: immunoselection and immunosubversion","volume":"6","author":"Zitvogel","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"key20180107210345_b10-or-32-06-2365","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20180107210345_b11-or-32-06-2365","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/jnci\/djm083","article-title":"Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier","volume":"99","author":"Seike","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"key20180107210345_b12-or-32-06-2365","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"key20180107210345_b13-or-32-06-2365","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI1555","article-title":"Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis","volume":"101","author":"Coughlin","year":"1998","journal-title":"J Clin Invest"},{"key":"key20180107210345_b14-or-32-06-2365","first-page":"884","article-title":"Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells","volume":"61","author":"Son","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107210345_b15-or-32-06-2365","first-page":"329","article-title":"The dual effects of interleukin-18 in tumor progression","volume":"4","author":"Park","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"key20180107210345_b16-or-32-06-2365","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"Ras is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"key20180107210345_b17-or-32-06-2365","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"key20180107210345_b18-or-32-06-2365","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","article-title":"Unique microRNA molecular profiles in lung cancer diagnosis and prognosis","volume":"9","author":"Yanaihara","year":"2006","journal-title":"Cancer Cell"},{"key":"key20180107210345_b19-or-32-06-2365","doi-asserted-by":"crossref","first-page":"12085","DOI":"10.1073\/pnas.0905234106","article-title":"MiR-21 is an EGFR-regulated anti-apoptonic factor in lung cancer in never-smokers","volume":"106","author":"Seike","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107210345_b20-or-32-06-2365","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107210345_b21-or-32-06-2365","article-title":"Protumorigenic effects of miR-145 loss in malignant pleural mesothelioma","author":"Cioce","year":"2013","journal-title":"Oncogene"},{"key":"key20180107210345_b22-or-32-06-2365","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/bjc.2012.7","article-title":"Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules","volume":"106","author":"Shimokawa","year":"2012","journal-title":"Br J Cancer"},{"key":"key20180107210345_b23-or-32-06-2365","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1471-2407-6-174","article-title":"Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database","volume":"6","author":"Gemma","year":"2006","journal-title":"BMC Cancer"},{"key":"key20180107210345_b24-or-32-06-2365","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1535-7163.MCT-13-0448","article-title":"MiR-134\/487b\/655 cluster regulates TGF-\u03b2-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells","volume":"13","author":"Kitamura","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"key20180107210345_b25-or-32-06-2365","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1200\/JCO.1999.17.10.3009","article-title":"Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin","volume":"17","author":"Thodtmann","year":"1999","journal-title":"J Clin Oncol"},{"key":"key20180107210345_b26-or-32-06-2365","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1158\/1078-0432.CCR-08-2999","article-title":"A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer","volume":"15","author":"Fakih","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107210345_b27-or-32-06-2365","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1158\/1535-7163.MCT-07-2140","article-title":"Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model","volume":"7","author":"Miyanaga","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"key20180107210345_b28-or-32-06-2365","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10555-006-9000-8","article-title":"The paradox of pro-inflammatory cytokines in cancer","volume":"25","author":"Dinarello","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"key20180107210345_b29-or-32-06-2365","doi-asserted-by":"crossref","first-page":"e37361","DOI":"10.1371\/journal.pone.0037361","article-title":"Identification of microRNAs inhibiting TGF-\u03b2-induced IL-11 production in bone metastatic breast cancer cells","volume":"7","author":"Pollari","year":"2012","journal-title":"PLoS One"},{"key":"key20180107210345_b30-or-32-06-2365","doi-asserted-by":"crossref","first-page":"e68753","DOI":"10.1371\/journal.pone.0068753","article-title":"miR-379 regulates cyclin B1 expression and is decreased in breast cancer","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS One"},{"key":"key20180107210345_b31-or-32-06-2365","doi-asserted-by":"crossref","first-page":"e24684","DOI":"10.1371\/journal.pone.0024684","article-title":"Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7\/Dox","volume":"6","author":"Yao","year":"2011","journal-title":"PLoS One"},{"key":"key20180107210345_b32-or-32-06-2365","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1158\/0008-5472.CAN-11-0993","article-title":"IL-18 induces PD-1-dependent immunosuppression in cancer","volume":"71","author":"Terme","year":"2011","journal-title":"Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3481\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:03:57Z","timestamp":1515359037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,16]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,9,16]]},"published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.3892\/or.2014.3481"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3481","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,16]]}}}